Dose A KER-012
KER-012-A201
Phase 2 mab completed
Quick answer
Dose A KER-012 for Pulmonary Arterial Hypertension is a Phase 2 program (mab) at Keros Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Keros Therapeutics
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 2
- Modality
- mab
- Status
- completed